US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Psyence Biomedical Ltd

2.62

-0.0389-1.47%

Post-market: 2.640.0239+0.91%17:39 EST

Volume:29.79K

Turnover:75.74K

Market Cap:2.67M

PE:-1.24

High:2.65

Open:2.65

Low:2.42

Close:2.66

52wk High:74.94

52wk Low:2.42

Shares:1.02M

Float Shares:970.74K

Volume Ratio:0.43

T/O Rate:3.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1050

EPS(LYR):32.76

ROE:-74.29%

ROA:-34.44%

PB:0.23

PE(LYR):0.08

Loading ...

Overview Company News Filings

Psyence BioMed Shareholders Approve Up to 250-for-1 Share Consolidation Authority

Psyence Biomedical announces results of annual, special meeting

Press Release: Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders

Psyence Biomedical board approves put option agreement with PsyLabs

Psyence Biomed Approves Put Option Agreement With Psylabs to Secure Strategic Supply and Strengthen Commercialization Pathway

THOMSON REUTERS

Psyence BioMed Secures Equity Option for Stake in PsyLabs

BRIEF-Psyence Biomed Announces Settlement Of Shareholder Litigation

Psyence Biomedical Settles Shareholder Litigation with KAOS Capital for $1.5 Million

Psyence Biomedical Ltd - Settlement to Be Funded by Cash on Hand

THOMSON REUTERS

Psyence Biomed Announces Settlement of Shareholder Litigation

THOMSON REUTERS

Psyence Biomedical Ltd - Co to Pay $1.5 Mln to Kaos Capital Under Settlement

THOMSON REUTERS

Cigna's Reassurances About PBM Business Lift Stock -- WSJ

CVS Health Faces New PBM Transparency Test With Earnings Engine In Focus

Simply Wall St.

Top Premarket Decliners

MT Newswires Live

NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:31 AM

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM

Psyence Biomedical Ltd trading halted, news pending

Psyence Biomedical Announces 1-for-6.25 Reverse Stock Split Effective February 2

Psyence Biomed Announces Effective Date for 1-for-6.25 Reverse Stock Split

THOMSON REUTERS

Press Release: MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PBM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBM\",,,,,undefined,":{"symbol":"PBM","market":"US","secType":"STK","nameCN":"Psyence Biomedical Ltd","latestPrice":2.6161,"timestamp":1771534800000,"preClose":2.655,"halted":0,"volume":29792,"hourTrading":{"tag":"盘后","latestPrice":2.64,"preClose":2.6161,"latestTime":"17:39 EST","volume":494,"amount":1300.518232,"timestamp":1771540767704,"change":0.0239,"changeRate":0.009136,"amplitude":0.034402},"delay":0,"changeRate":-0.014651600753295645,"floatShares":970736,"shares":1022200,"eps":-2.105,"marketStatus":"Post-Mkt","change":-0.0389,"latestTime":"02-19 18:06:17 EST","open":2.65,"high":2.65,"low":2.42,"amount":75740.52931200001,"amplitude":0.086629,"askPrice":2.79,"askSize":110,"bidPrice":2.53,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-2.105,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771549200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":2.655,"preHourTrading":{"tag":"盘前","latestPrice":2.72,"preClose":2.655,"latestTime":"08:38 EST","volume":75,"amount":197.23999500000002,"timestamp":1771508336736,"change":0.065,"changeRate":0.024482,"amplitude":0.045198},"postHourTrading":{"tag":"盘后","latestPrice":2.64,"preClose":2.6161,"latestTime":"17:39 EST","volume":494,"amount":1300.518232,"timestamp":1771540767704,"change":0.0239,"changeRate":0.009136,"amplitude":0.034402},"volumeRatio":0.434663},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBM\",,,,,undefined,":{"symbol":"PBM","floatShares":970736,"roa":"-34.44%","roe":"-74.29%","lyrEps":32.757919,"volumeRatio":0.434663,"shares":1022200,"dividePrice":0,"high":2.65,"amplitude":0.086629,"preClose":2.655,"low":2.42,"week52Low":2.42,"pbRate":"0.23","week52High":74.9375,"institutionHeld":0.0125,"latestPrice":2.6161,"committee":-0.981982,"eps":-2.105,"divideRate":0,"volume":29792,"delay":0,"ttmEps":-2.105,"open":2.65,"prevYearClose":4.7088,"prevWeekClose":3.09,"prevMonthClose":4.0038,"prevQuarterClose":4.7088,"fiveDayClose":2.96,"twentyDayClose":5.4425,"sixtyDayClose":10.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-02","symbol":"PBM","defaultRemindTime":1770042600000,"type":"split","dateTimestamp":1770008400000,"forFactor":625,"toFactor":100,"ratio":6.25},{"market":"US","date":"2025-05-05","symbol":"PBM","defaultRemindTime":1746451800000,"type":"split","dateTimestamp":1746417600000,"forFactor":797,"toFactor":100,"ratio":7.97},{"market":"US","date":"2024-11-26","symbol":"PBM","defaultRemindTime":1732631400000,"type":"split","dateTimestamp":1732597200000,"forFactor":75,"toFactor":1,"ratio":75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBM","date":"2026-02-18","current":-1.230784,"percent":0.301961,"low":-8.987173,"twenty":-1.254576,"median":-0.085527,"eighty":1.36046,"high":43.62106,"avg":0.556036,"sd":5.928604,"marketCap":2851871},"quantilePoints":[{"date":"2024-02-09","current":-4.032357,"twenty":-6.238869,"median":-6.072412,"eighty":-4.789887,"marketCap":12687649},{"date":"2024-02-16","current":-2.839339,"twenty":-6.098548,"median":-3.798256,"eighty":-3.119893,"marketCap":8908805},{"date":"2024-02-23","current":-2.317077,"twenty":-5.416526,"median":-3.308726,"eighty":-2.830575,"marketCap":7275145},{"date":"2024-03-01","current":-2.358335,"twenty":-4.411122,"median":-2.857169,"eighty":-2.443954,"marketCap":7364862},{"date":"2024-03-08","current":-5.40272,"twenty":-4.595223,"median":-2.890292,"eighty":-2.448252,"marketCap":17006136},{"date":"2024-03-15","current":-6.789855,"twenty":-5.670597,"median":-3.448439,"eighty":-2.49853,"marketCap":21291147},{"date":"2024-03-22","current":-4.959176,"twenty":-5.522615,"median":-3.851628,"eighty":-2.531651,"marketCap":15533164},{"date":"2024-03-28","current":-5.045126,"twenty":-5.473209,"median":-4.390178,"eighty":-2.58397,"marketCap":15800977},{"date":"2024-04-05","current":-4.43423,"twenty":-5.384879,"median":-4.562142,"eighty":-2.723572,"marketCap":13926285},{"date":"2024-04-12","current":-3.616183,"twenty":-5.308825,"median":-4.386712,"eighty":-2.826193,"marketCap":11169148},{"date":"2024-04-19","current":-2.969424,"twenty":-5.158983,"median":-4.227564,"eighty":-2.846471,"marketCap":9153854},{"date":"2024-04-26","current":-3.634228,"twenty":-5.044947,"median":-3.989124,"eighty":-2.883667,"marketCap":11244136},{"date":"2024-05-03","current":-5.498334,"twenty":-5.135216,"median":-4.022166,"eighty":-2.931227,"marketCap":17006136},{"date":"2024-05-10","current":-4.755664,"twenty":-5.044947,"median":-4.198236,"eighty":-2.950931,"marketCap":14729724},{"date":"2024-05-17","current":-3.914422,"twenty":-5.029183,"median":-4.161003,"eighty":-2.965515,"marketCap":12185499},{"date":"2024-05-24","current":-3.576034,"twenty":-4.995271,"median":-3.989124,"eighty":-2.992841,"marketCap":11063362},{"date":"2024-05-31","current":-2.410174,"twenty":-4.97525,"median":-3.912167,"eighty":-2.927321,"marketCap":10042674},{"date":"2024-06-07","current":-2.153089,"twenty":-4.945403,"median":-3.739796,"eighty":-2.692286,"marketCap":8971456},{"date":"2024-06-14","current":-1.939708,"twenty":-4.890182,"median":-3.700097,"eighty":-2.466859,"marketCap":8082344},{"date":"2024-06-21","current":-1.253291,"twenty":-4.889663,"median":-3.668675,"eighty":-2.422386,"marketCap":5222190},{"date":"2024-06-28","current":-0.96407,"twenty":-4.844987,"median":-3.634228,"eighty":-2.361971,"marketCap":4017069},{"date":"2024-07-05","current":-0.935148,"twenty":-4.815866,"median":-3.576034,"eighty":-2.32332,"marketCap":3896557},{"date":"2024-07-12","current":-0.998455,"twenty":-4.766248,"median":-3.491099,"eighty":-2.088818,"marketCap":4160345},{"date":"2024-07-19","current":-1.323989,"twenty":-4.726555,"median":-3.448439,"eighty":-1.937394,"marketCap":5516775},{"date":"2024-07-26","current":-1.867403,"twenty":-4.683035,"median":-3.197485,"eighty":-1.910851,"marketCap":7781064},{"date":"2024-08-02","current":-0.143956,"twenty":-4.658595,"median":-2.969424,"eighty":-1.31949,"marketCap":7364628},{"date":"2024-08-09","current":-0.138564,"twenty":-4.597134,"median":-2.93318,"eighty":-1.252648,"marketCap":7088789},{"date":"2024-08-16","current":-0.175224,"twenty":-4.56626,"median":-2.839339,"eighty":-1.14223,"marketCap":8964295},{"date":"2024-08-23","current":-0.164846,"twenty":-4.484876,"median":-2.620747,"eighty":-1.025128,"marketCap":8433350},{"date":"2024-08-30","current":-0.133743,"twenty":-4.446042,"median":-2.530201,"eighty":-0.96664,"marketCap":6842183},{"date":"2024-09-06","current":-0.062172,"twenty":-4.437003,"median":-2.444094,"eighty":-0.946331,"marketCap":3180663},{"date":"2024-09-13","current":-0.050913,"twenty":-4.377208,"median":-2.41628,"eighty":-0.171823,"marketCap":2604637},{"date":"2024-09-20","current":-0.039131,"twenty":-4.329259,"median":-2.362614,"eighty":-0.163756,"marketCap":2001897},{"date":"2024-09-27","current":-0.035312,"twenty":-4.305444,"median":-2.355493,"eighty":-0.148457,"marketCap":1806550},{"date":"2024-10-04","current":-0.032669,"twenty":-4.254131,"median":-2.317077,"eighty":-0.14305,"marketCap":1671309},{"date":"2024-10-11","current":-0.031494,"twenty":-4.19237,"median":-2.120953,"eighty":-0.135288,"marketCap":1611202},{"date":"2024-10-18","current":-0.035247,"twenty":-4.164165,"median":-2.088818,"eighty":-0.127633,"marketCap":1803210},{"date":"2024-10-25","current":-0.031592,"twenty":-4.083815,"median":-1.933924,"eighty":-0.075611,"marketCap":1616211},{"date":"2024-11-01","current":-0.02265,"twenty":-4.026242,"median":-1.927818,"eighty":-0.057485,"marketCap":1158729},{"date":"2024-11-08","current":-0.024869,"twenty":-3.982516,"median":-1.638758,"eighty":-0.044294,"marketCap":1272265},{"date":"2024-11-15","current":-0.049784,"twenty":-3.931086,"median":-1.323989,"eighty":-0.044294,"marketCap":2546883},{"date":"2024-11-22","current":-0.042798,"twenty":-3.911717,"median":-1.256183,"eighty":-0.044338,"marketCap":2189514},{"date":"2024-11-29","current":-0.045389,"twenty":-3.854339,"median":-1.251684,"eighty":-0.044435,"marketCap":2322054},{"date":"2024-12-06","current":-0.046144,"twenty":-3.758505,"median":-1.181949,"eighty":-0.045374,"marketCap":2360678},{"date":"2024-12-13","current":-0.036019,"twenty":-3.736446,"median":-1.098558,"eighty":-0.042081,"marketCap":1842723},{"date":"2024-12-20","current":-0.213027,"twenty":-3.720507,"median":-1.025128,"eighty":-0.041056,"marketCap":10898254},{"date":"2024-12-27","current":-0.195572,"twenty":-3.702521,"median":-0.998455,"eighty":-0.041494,"marketCap":10005291},{"date":"2025-01-03","current":-0.174804,"twenty":-3.696057,"median":-0.967283,"eighty":-0.041676,"marketCap":8942782},{"date":"2025-01-10","current":-0.147112,"twenty":-3.67593,"median":-0.957643,"eighty":-0.042486,"marketCap":7526104},{"date":"2025-01-17","current":-0.1549,"twenty":-3.667341,"median":-0.574087,"eighty":-0.042776,"marketCap":7924545},{"date":"2025-01-24","current":-0.172934,"twenty":-3.665023,"median":-0.208553,"eighty":-0.043408,"marketCap":8057358},{"date":"2025-01-31","current":-0.14918,"twenty":-3.646165,"median":-0.184323,"eighty":-0.044744,"marketCap":6950578},{"date":"2025-02-07","current":-0.129701,"twenty":-3.623401,"median":-0.178377,"eighty":-0.045379,"marketCap":6043019},{"date":"2025-02-14","current":-0.132551,"twenty":-3.592094,"median":-0.174804,"eighty":-0.045783,"marketCap":6175832},{"date":"2025-02-21","current":-0.123525,"twenty":-3.571282,"median":-0.172934,"eighty":-0.046085,"marketCap":5755256},{"date":"2025-02-28","current":-0.117823,"twenty":-3.543472,"median":-0.170272,"eighty":-0.046183,"marketCap":5489629},{"date":"2025-03-07","current":-0.087417,"twenty":-3.495369,"median":-0.16615,"eighty":-0.046596,"marketCap":4072950},{"date":"2025-03-14","current":-0.074485,"twenty":-3.463351,"median":-0.163664,"eighty":-0.047435,"marketCap":3470419},{"date":"2025-03-21","current":-0.059349,"twenty":-3.451625,"median":-0.159632,"eighty":-0.048363,"marketCap":2765179},{"date":"2025-03-28","current":-0.05971,"twenty":-3.386977,"median":-0.158361,"eighty":-0.049116,"marketCap":2782002},{"date":"2025-04-04","current":-0.04489,"twenty":-3.267253,"median":-0.1549,"eighty":-0.049116,"marketCap":2091532},{"date":"2025-04-11","current":-0.043618,"twenty":-3.203179,"median":-0.154152,"eighty":-0.046323,"marketCap":2032227},{"date":"2025-04-17","current":-0.042568,"twenty":-3.140804,"median":-0.151236,"eighty":-0.046065,"marketCap":1983334},{"date":"2025-04-25","current":-0.053422,"twenty":-3.016258,"median":-0.148843,"eighty":-0.045369,"marketCap":2489014},{"date":"2025-05-02","current":-0.04217,"twenty":-2.968121,"median":-0.146958,"eighty":-0.044944,"marketCap":1964773},{"date":"2025-05-09","current":-0.047195,"twenty":-2.958916,"median":-0.143956,"eighty":-0.045202,"marketCap":2198901},{"date":"2025-05-16","current":-0.065096,"twenty":-2.939039,"median":-0.143033,"eighty":-0.045369,"marketCap":3032967},{"date":"2025-05-23","current":-0.055332,"twenty":-2.910166,"median":-0.139192,"eighty":-0.045482,"marketCap":2578022},{"date":"2025-05-30","current":-0.065345,"twenty":-2.857169,"median":-0.138564,"eighty":-0.045852,"marketCap":3044574},{"date":"2025-06-06","current":-0.063844,"twenty":-2.839339,"median":-0.135018,"eighty":-0.046045,"marketCap":2974641},{"date":"2025-06-13","current":-0.058023,"twenty":-2.817429,"median":-0.132806,"eighty":-0.046068,"marketCap":2703424},{"date":"2025-06-20","current":-0.061591,"twenty":-2.692286,"median":-0.131126,"eighty":-0.046129,"marketCap":2869653},{"date":"2025-06-27","current":26.979573,"twenty":-2.596595,"median":-0.130176,"eighty":-0.046129,"marketCap":27297662},{"date":"2025-07-03","current":27.487604,"twenty":-2.551768,"median":-0.129464,"eighty":-0.045667,"marketCap":27811683},{"date":"2025-07-11","current":26.19376,"twenty":-2.531167,"median":-0.127325,"eighty":-0.04489,"marketCap":26502584},{"date":"2025-07-18","current":27.61963,"twenty":-2.482695,"median":-0.125116,"eighty":-0.043883,"marketCap":27945265},{"date":"2025-07-25","current":5.7589,"twenty":-2.446866,"median":-0.121624,"eighty":-0.042776,"marketCap":5826797},{"date":"2025-08-01","current":2.899625,"twenty":-2.443883,"median":-0.117823,"eighty":-0.042564,"marketCap":2933812},{"date":"2025-08-08","current":2.409629,"twenty":-2.430929,"median":-0.116873,"eighty":-0.041187,"marketCap":2438039},{"date":"2025-08-15","current":1.931163,"twenty":-2.415059,"median":-0.115922,"eighty":-0.040303,"marketCap":1953931},{"date":"2025-08-22","current":1.844692,"twenty":-2.395713,"median":-0.095437,"eighty":-0.03915,"marketCap":1866441},{"date":"2025-08-29","current":1.712105,"twenty":-2.371998,"median":-0.086044,"eighty":-0.036019,"marketCap":1732291},{"date":"2025-09-05","current":1.487283,"twenty":-2.362357,"median":-0.084153,"eighty":-0.035684,"marketCap":1504818},{"date":"2025-09-12","current":1.867751,"twenty":-2.360517,"median":-0.075977,"eighty":-0.035051,"marketCap":1889772},{"date":"2025-09-19","current":3.055271,"twenty":-2.356062,"median":-0.074774,"eighty":-0.033798,"marketCap":3091293},{"date":"2025-09-26","current":1.769752,"twenty":-2.341544,"median":-0.069101,"eighty":-0.031722,"marketCap":1790617},{"date":"2025-10-03","current":1.896574,"twenty":-2.321759,"median":-0.068517,"eighty":-0.030678,"marketCap":1918935},{"date":"2025-10-10","current":2.132926,"twenty":-2.285546,"median":-0.066599,"eighty":-0.029539,"marketCap":2158073},{"date":"2025-10-17","current":1.988809,"twenty":-2.204185,"median":-0.065502,"eighty":-0.025065,"marketCap":2012257},{"date":"2025-10-24","current":1.922516,"twenty":-2.127381,"median":-0.065096,"eighty":-0.022271,"marketCap":1945182},{"date":"2025-10-31","current":1.80434,"twenty":-2.088818,"median":-0.063691,"eighty":1.436554,"marketCap":1825613},{"date":"2025-11-07","current":1.448659,"twenty":-2.088818,"median":-0.062888,"eighty":1.555882,"marketCap":1465739},{"date":"2025-11-14","current":1.608341,"twenty":-2.06311,"median":-0.062194,"eighty":1.555882,"marketCap":1627303},{"date":"2025-11-21","current":3.182406,"twenty":-1.990611,"median":-0.061648,"eighty":1.615259,"marketCap":3219927},{"date":"2025-11-28","current":-0.729044,"twenty":-1.937394,"median":-0.062172,"eighty":1.602576,"marketCap":2873598},{"date":"2025-12-05","current":-0.859655,"twenty":-1.92814,"median":-0.062562,"eighty":1.576058,"marketCap":3388412},{"date":"2025-12-12","current":-0.736168,"twenty":-1.928076,"median":-0.063663,"eighty":1.561647,"marketCap":2901679},{"date":"2025-12-19","current":-0.693423,"twenty":-1.926597,"median":-0.06447,"eighty":1.557612,"marketCap":2733194},{"date":"2025-12-26","current":-0.422703,"twenty":-1.921713,"median":-0.065346,"eighty":1.550694,"marketCap":1666125},{"date":"2026-01-02","current":-0.357825,"twenty":-1.878265,"median":-0.066038,"eighty":1.541471,"marketCap":1410403},{"date":"2026-01-09","current":-0.364854,"twenty":-1.501571,"median":-0.067537,"eighty":1.529941,"marketCap":1438109},{"date":"2026-01-16","current":-1.086109,"twenty":-1.384919,"median":-0.068687,"eighty":1.495353,"marketCap":4281003},{"date":"2026-01-23","current":-1.232306,"twenty":-1.345841,"median":-0.070643,"eighty":1.476907,"marketCap":4857255},{"date":"2026-01-30","current":-1.16796,"twenty":-1.310492,"median":-0.075063,"eighty":1.457191,"marketCap":4603628},{"date":"2026-02-06","current":-0.749465,"twenty":-1.275272,"median":-0.079702,"eighty":1.433787,"marketCap":2954088},{"date":"2026-02-13","current":-0.728718,"twenty":-1.255862,"median":-0.084567,"eighty":1.385825,"marketCap":2872314},{"date":"2026-02-18","current":-0.723532,"twenty":-1.254576,"median":-0.085527,"eighty":1.36046,"marketCap":2851871}],"updateTime":1771517626607},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612486402","title":"Psyence BioMed Shareholders Approve Up to 250-for-1 Share Consolidation Authority","url":"https://stock-news.laohu8.com/highlight/detail?id=2612486402","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612486402?lang=en_us&edition=fundamental","pubTime":"2026-02-19 20:20","pubTimestamp":1771503620,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. said shareholders approved a special resolution authorizing its board to implement one or more consolidations of the company’s common shares at a ratio of up to 250-to-1. The company said it will provide additional disclosure if and when the board decides to proceed, including the final ratio and effective date, subject to applicable approvals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDLkwTrf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2612468109","title":"Psyence Biomedical announces results of annual, special meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2612468109","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612468109?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:27","pubTimestamp":1771338462,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) announced the voting results from its Annual and Special Meeting of Shareholders, held at 9:00 a.m. Eastern Time on Februa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-announces-results-of-annual-special-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-announces-results-of-annual-special-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2612450758","title":"Press Release: Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2612450758","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612450758?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:15","pubTimestamp":1771337700,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 17, 2026  -- Psyence Biomedical Ltd.  , a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced the voting results from its Annual and Special Meeting of Shareholders , held at 9:00 a.m. Eastern Time on February 12, 2026. Shareholders voted in favour of all matters of business presented at the Meeting, including the election of directors, the appointment of auditors and the approval of share consolidation authority for the board of directors .The Company will provide additional disclosure if and when the Board determines to implement any share consolidation, including the final consolidation ratio and effective date, subject to applicable regulatory and exchange approvals.Further details regarding the matters voted on at the Meeting are set out in the Company's management information circular, which is available under the Company's profile on EDGAR.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2611207199","title":"Psyence Biomedical board approves put option agreement with PsyLabs","url":"https://stock-news.laohu8.com/highlight/detail?id=2611207199","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611207199?lang=en_us&edition=fundamental","pubTime":"2026-02-14 07:35","pubTimestamp":1771025711,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) announced that its board of directors has ratified the entry into a put option agreement with PsyLabs, a developer and man...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-board-approves-put-option-agreement-with-psylabs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-board-approves-put-option-agreement-with-psylabs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2611199478","title":"Psyence Biomed Approves Put Option Agreement With Psylabs to Secure Strategic Supply and Strengthen Commercialization Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2611199478","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611199478?lang=en_us&edition=fundamental","pubTime":"2026-02-14 07:30","pubTimestamp":1771025402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nTUA3XYRQG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2611272198","title":"Psyence BioMed Secures Equity Option for Stake in PsyLabs","url":"https://stock-news.laohu8.com/highlight/detail?id=2611272198","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611272198?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:02","pubTimestamp":1771016525,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. has approved a put option agreement with PsyLabs, a leading manufacturer of pharmaceutical-grade psychedelic compounds. Under the agreement, PsyLabs is granted the right, but not the obligation, to require Psyence BioMed to make an additional equity investment in PsyLabs through a share-for-share exchange at fair market value, subject to specified terms and conditions. This arrangement is part of a broader strategic relationship, which also includes licensing access to PsyLabs’ manufacturing capabilities. The agreement was reviewed and ratified by a special committee of independent directors, with an independent third-party valuation considered in the decision. Key executives from Psyence BioMed collectively hold less than 13% of PsyLabs' outstanding shares. The transaction is structured to secure reliable supply and commercial alignment while preserving Psyence BioMed’s near-term financial flexibility.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL7qmmqW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2610955778","title":"BRIEF-Psyence Biomed Announces Settlement Of Shareholder Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2610955778","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610955778?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:31","pubTimestamp":1770820285,"startTime":"0","endTime":"0","summary":"BRIEF-Psyence Biomed Announces Settlement Of Shareholder LitigationFeb 11 (Reuters) - Psyence Biomedical Ltd PBM.O:PSYENCE BIOMED ANNOUNCES SETTLEMENT OF SHAREHOLDER LITIGATIONPSYENCE BIOMEDICAL LTD -","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUARNXQ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2610955321","title":"Psyence Biomedical Settles Shareholder Litigation with KAOS Capital for $1.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610955321","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610955321?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819310,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. has settled a shareholder litigation claim brought by KAOS Capital Ltd. The dispute centered on allegations by KAOS of improper and oppressive actions by the company, which Psyence Biomedical and its leadership denied. As part of the settlement, Psyence Biomedical will pay KAOS a total of $1.5 million and will release KAOS from a prior court-ordered payment of CAD $75,000 in costs. KAOS has agreed to sell all its shares in the company to a third party at $5 per share and to fully retract its allegations. The settlement includes mutual releases of all claims and does not constitute an admission of wrongdoing by any party. The company expects to fund the settlement with cash on hand.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDLc37fR6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210150020.SGD","LU0314104364.USD","PBM","BK4585","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","NDAQ","IE00BKPKM429.USD","SG9999014013.SGD","IE00B64PRP62.GBP","BK4139","SG9999014039.USD","SG9999014005.SGD","LU2210149790.SGD","SG9999014021.USD"],"gpt_icon":0},{"id":"2610955360","title":"Psyence Biomedical Ltd - Settlement to Be Funded by Cash on Hand","url":"https://stock-news.laohu8.com/highlight/detail?id=2610955360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610955360?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUARNXQ9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2610295539","title":"Psyence Biomed Announces Settlement of Shareholder Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2610295539","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610295539?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUARNXQ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2610095535","title":"Psyence Biomedical Ltd - Co to Pay $1.5 Mln to Kaos Capital Under Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2610095535","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610095535?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUARNXQ9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2609598300","title":"Cigna's Reassurances About PBM Business Lift Stock -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2609598300","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609598300?lang=en_us&edition=fundamental","pubTime":"2026-02-06 00:47","pubTimestamp":1770310020,"startTime":"0","endTime":"0","summary":"Cigna Group's shares are up about 3% in trading Thursday, showing that investors don't think the recent round of changes out of Washington will fundamentally alter the company's outlook.Cigna is the parent of one of the largest pharmacy-benefit managers. On Wednesday, the Federal Trade Commission announced a settlement with the company. That came right after President Trump signed legislation that included new provisions designed to add transparency and other tweaks to PBMs' business.Cigna Chief Executive David Cordani told analysts on its Thursday earnings call that all of the policy moves will leave the PBM's margins, and its growth trajectory, largely unchanged, partly because it unveiled a new PBM setup last October that already incorporated an approach similar to the new requirements.The company might see a tax-rate increase of as much as 1% over time from moving one operation to the U.S., he said. He also said that Cigna expects most, but not all, clients to switch to a new PBM s","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","BK4196","LU1261432733.SGD","IE00B19Z3581.USD","LU0058720904.USD","IE00BSNM7G36.USD","LU0289739699.SGD","IE0002270589.USD","LU0868494617.USD","BK4588","CI","BK4139","BK4585","LU1059921491.USD","PBM"],"gpt_icon":0},{"id":"2609342681","title":"CVS Health Faces New PBM Transparency Test With Earnings Engine In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2609342681","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609342681?lang=en_us&edition=fundamental","pubTime":"2026-02-05 10:39","pubTimestamp":1770259147,"startTime":"0","endTime":"0","summary":"The U.S. Department of Labor has proposed a rule that would require pharmacy benefit managers to fully disclose all compensation to self insured group health plans.\nThe rule would apply to PBMs owned by major healthcare companies, including CVS Health (NYSE:CVS).\nIf adopted, the proposal would significantly increase transparency around PBM fees, rebates, and other revenue streams.\n\nFor CVS Health, which combines retail pharmacies, insurance, and PBM operations, this proposal shines a light...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-faces-new-pbm-transparency-test-with-earnings-eng","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-faces-new-pbm-transparency-test-with-earnings-eng","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CVS","PBM"],"gpt_icon":0},{"id":"2608387661","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2608387661","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608387661?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:45","pubTimestamp":1770122727,"startTime":"0","endTime":"0","summary":"Julong  shares were over 22% lower pre-bell Tuesday, erasing gains from the previous session.PayPal  stock was down 15% after the company reported Q4 non-GAAP earnings and revenue that trailed analysts' estimates.Psyence Biomedical  shares were 11% lower, adding to Monday's losses.Thomson Reuters  stock was down 10% after RBC cut its price target to $155 from $177.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2023251221.USD","BK4585","BK4524","LU1861220033.SGD","IE00BQXX3C00.GBP","LU1861220207.SGD","BK4581","LU2089284900.SGD","LU0158827948.USD","TRI","LU1668664300.SGD","LU2089283258.USD","LU1861215975.USD","LU0106831901.USD","LU1989763005.USD","BK4551","BK4123","BK4579","LU1989773731.SGD","BK4106","BK4554","BK7094","PYPG","PYPY","BK4227","BK4535","PBM","JLHL","LU2290526834.HKD","LU2360107168.USD","LU2360107671.USD","PYPL","BK4566","LU1791807156.HKD","IE00BQXX3F31.USD","BK4534","BK4527","BK4533","BK4588","BK4139","BK4129","BK4598","IE00BQXX3D17.EUR","LU1861217088.USD"],"gpt_icon":0},{"id":"2608416867","title":"NASDAQ TRADE HALT CONTINUES  VOLATILITY TRADING PAUSE AT 09:31 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2608416867","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608416867?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:31","pubTimestamp":1770042696,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  VOLATILITY TRADING PAUSE AT 09:31 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nAQN2LKANJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2608048140","title":"NASDAQ TRADE HALT CONTINUES  HALT NEWS PENDING AT 03:28 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2608048140","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608048140?lang=en_us&edition=fundamental","pubTime":"2026-02-01 16:28","pubTimestamp":1769934526,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  HALT NEWS PENDING AT 03:28 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nAQN2LK90T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2607507869","title":"Psyence Biomedical Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2607507869","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607507869?lang=en_us&edition=fundamental","pubTime":"2026-01-31 08:50","pubTimestamp":1769820626,"startTime":"0","endTime":"0","summary":"19:50 EST Psyence Biomedical (PBM) Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-ltd-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-ltd-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2607721984","title":"Psyence Biomedical Announces 1-for-6.25 Reverse Stock Split Effective February 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2607721984","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607721984?lang=en_us&edition=fundamental","pubTime":"2026-01-29 07:30","pubTimestamp":1769643008,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. has announced a 1-for-6.25 reverse stock split of its common shares, effective at the opening of the market on February 2, 2026. Following the consolidation, the shares will continue trading under the symbol \"PBM\" on the Nasdaq Capital Market with a new CUSIP number 74449F407. The consolidation will affect all shareholders uniformly, with minor adjustments for fractional shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL9pQFgQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU0314104364.USD","PBM","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014013.SGD","LU2095319765.USD","BK4585","BK4112","LU2210150020.SGD","BK4588","SG9999014005.SGD","SG9999014021.USD","BK4139","IE00BKPKM429.USD","LU2210149790.SGD","NDAQ","SG9999014039.USD"],"gpt_icon":0},{"id":"2607072168","title":"Psyence Biomed Announces Effective Date for 1-for-6.25 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2607072168","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607072168?lang=en_us&edition=fundamental","pubTime":"2026-01-29 07:30","pubTimestamp":1769643000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA9YMNL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2606921782","title":"Press Release: MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH","url":"https://stock-news.laohu8.com/highlight/detail?id=2606921782","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606921782?lang=en_us&edition=fundamental","pubTime":"2026-01-27 21:23","pubTimestamp":1769520180,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc.  , a leader in innovative healthcare technology, Pharmacy Benefit Management  and Third-Party Administration  services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings.Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy--a former HillCour portfolio company--which was acquired by Knipper in 2020. With a career spanning leadership roles in Pharmacy Benefit Management  and retail pharmacy operations, Davis brings a rare blend of operational rigor and innovative vision to the Marpai leadership team.\"MarpaiRx is at a pivotal inflection point, and we needed a leader who not only understands the complexities of the pharmacy landscape but knows how ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIMI","BK4139","BK4137","PBM","BK4173","MRAI","INC"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}]}}